Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:23 PM
Ignite Modification Date:
2025-12-24 @ 10:23 PM
NCT ID:
NCT03694535
Eligibility Criteria:
Inclusion Criteria:
* newly diagnosed or followed as recurrent intermediate-risk non muscle invasive non muscle invasive bladder cancer according to the criteria of European Association of Urology.
* newly diagnosed or followed as recurrent high-risk non muscle invasive non muscle invasive bladder cancer according to the criteria of European Association of Urology.
* pathology of urothelial carcinoma
Exclusion Criteria:
* Low bladder capacity (\<150ml)
* increased post voiding residual urine (\>150ml)
* untreatable or uncontrollable urinary tract infection
* history of urethral stricture
* presence of bladder diverticula larger than 1 cm
* pathology other than urothelial carcinoma
* WHO (World Health Organization) performance status \> 2
* upper urinary tract urothelial carcinoma diagnosis
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT03694535
Study Brief:
Protocol Section:
NCT03694535